Suchergebnisse - "Hochster, H"

PubPharm (105)

1

Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer

enthalten in: ESMO open | 2022

von Van Cutsem, E. | Hochster, H. | Shitara, K. | +11

2

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140) : an open-label, multicentre, phase 1b study

enthalten in: The Lancet. Oncology | 2020

von Lee, M. | Ryoo, B. | Hsu, C. | +38

CommentIn: Lancet Oncol. 2020 Jun;21(6):740-741. - PMID 32502436

3

Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Yoshino, T. | Cleary, J. | Van Cutsem, E. | +29

CommentIn: Ann Oncol. 2020 Jan;31(1):15-16. - PMID 31912790

4

CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR YOUNG PATIENTS WITH FIRST‐LINE FOLLICULAR LYMPHOMA: A POOLED ANALYSIS OF 4249 PATIENTS FROM THE FLASH DATABASE

enthalten in: Hematological oncology | 2017

von Fornecker, L. | Ou, F. | Dixon, J. | +21

5

PD-025RECOURSE trial: impact of adverse events on quality of life and duration of TAS-102 (trifluridine and tipiracil) treatment

enthalten in: Annals of oncology | 2016

von Tabernero, J. | Mayer Robert, J. | Ohtsu, A. | +16

6

PD-010Association between chemotherapy-induced neutropenia at 1-month and overall survival in patients receiving TAS-102 for metastatic colorectal cancer

enthalten in: Annals of oncology | 2016

von Kotani, D. | Pashtoon, K. | Cecchini, M. | +6

7

Phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) in solid tumors: results from the pancreatic cancer (PC) and non-small cell lung cancer (NSCLC) cohorts

enthalten in: Annals of oncology | 2016

von George, B. | Kelly, K. | Ko, A. | +6

8

Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Bendell, J. | O'Reilly, E. | Middleton, M. | +5

9

Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Hochster, H. | Uboha, N. | Messersmith, W. | +8

ErratumIn: Cancer Chemother Pharmacol. 2015 Jan;75(1):25 Lenz, H-J [added]

10

Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancer

enthalten in: Annals of oncology | 2015

von Bendell, J. | O'Reilly, E. | Middleton, M. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]